Tag: early stage

BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).

James Altucher walks through what Starlink's expanding constellation signals about the company's future and why most investors haven't connected the dots.

Ahead of the expected June 12 listing, longtime tech analyst examines how a satellite service became the company's primary profit engine.

With a Nasdaq listing targeted for June 12, the longtime early stage technology investor walks through the timeline investors are watching.

Pepe Dollar ($PEPD) gains momentum as a best crypto presale while PEPETO nears fundraising completion during expanding Q3 2026 altcoin activity

ROAD TOWN, British Virgin Islands, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The LYNO AI presale has reached a key milestone, with more than 269,000 tokens sold during its Early Bird stage. Priced at $0.05 per token, this phase provides participants access before the price rises to $0.055 in the next stage. A total of 16 million tokens are available in this round, marking significant early engagement as the project progresses toward its upcoming phases.

First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile

New York, N.Y., Aug. 14, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today reported its third fiscal quarter financial results and provided a business update.